Skip to main content
High RiskFDAfda-H-0503-2025UNDECLARED ALLERGEN

Product is distributed in 10lb bulk packaging. Brown cardboard box with generic label. Raw Ramen Noodle HA #22W (4942) UPC: NONE Manufact...

Category
Units Affected
2,800
Recall Date
August 5, 2025
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0503-2025.

Ramen Noodle package label does not declare Soy as the source for lecithin ingredient.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0503-2025.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Kobayashi Noodle U.s.a. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0503-2025.

Kobayashi Noodle U.S.A.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Kobayashi Noodle U.s.a. Recall FAQ

Kobayashi Noodle U.s.a. is the subject of a food safety report: Product is distributed in 10lb bulk packaging. Brown cardboard box with generic label. Raw Ramen Noodle HA #22W (4942) UPC: NONE Manufact.... The notice was published on August 5, 2025 by the U.S. Food and Drug Administration (FDA). Approximately 2,800 units are potentially affected.